Quick Takeaways
- Cormorant Asset Management, LP filed SCHEDULE 13G/A for BRIGHT MINDS BIOSCIENCES INC. Common Shares (DRUG).
- Disclosed ownership: 9.7%.
- Date of event: 28 Apr 2026.
Cormorant Asset Management, LP - 28 Apr 2026 SCHEDULE 13G/A Report for BRIGHT MINDS BIOSCIENCES INC. Common Shares (DRUG)
- Filing Manager
- Cormorant Asset Management, LP
- Reporting Manager
- Cormorant Asset Management, LP
- Symbol
- DRUG
- Shares outstanding
- 9,783,728 shares
- Disclosed Ownership
- 950,000 shares
- Ownership
- 9.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Apr 2026, 16:08:47 UTC
- Date of event
- 28 Apr 2026
- Previous filing
- 06 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Cormorant Asset Management, LP disclosed 9.7% ownership in BRIGHT MINDS BIOSCIENCES INC. Common Shares (DRUG) on 28 Apr 2026."
What Changed
- Previous schedule filing date: 06 Feb 2026.
- Current filing was accepted on 30 Apr 2026, 16:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 9.7% | 950,000 | 0 | 950,000 | /s/ Bihua Chen | Bihua Chen, Managing Member | |
| Chen Bihua | 9.7% | 950,000 | 0 | 950,000 | /s/ Bihua Chen | Bihua Chen |